About Pacliklin 260 Paclitaxel Injection
Pacliklin 260 Paclitaxel Injection is an acclaimed anticancer therapeutic, designed to deliver unparalleled efficacy for metastatic cancers. Manufactured in accordance with the highest pharmacopoeia standards (IP), this select formulation guarantees instant savings through its excellent quality and trusted results. With a strength of 260 mg in a 43.4 mL brown vial, it ensures reliable intravenous administration for adults. Recommended for various cancers and approved for hospital supply, Pacliklin 260 stands out as an incomparable solution, packaged with precision and safety. Prescription required. Made in India, shelf life 24 months.
Exceptional Application and Unmatched Benefits
Pacliklin 260 Paclitaxel Injection is expertly developed for adult intravenous use in hospital settings, targeting a broad range of metastatic cancers. Its primary application surface is within oncology wards, where it offers a highly dependable solution for patients. This injectable solution provides excellent therapeutic action, assuring superiority over generic alternatives. The competitive advantage lies in its adherence to select pharmacopoeia standards and consistent, reliable results-qualities that make it a preferred choice for leading healthcare providers across India.
Instant Packaging Details and Swift Dispatch Services
Each Pacliklin 260 vial comes securely packed in a white/blue-labelled brown vial, contained within a robust box. The packaging guarantees product integrity during transportation and storage, remaining stable below 25C. Certified for quality and safety, all vials are promptly dispatched using express shipping and advanced transport services, minimizing delivery times to hospitals across India. Delivery time is kept efficient and reliable to support healthcare facilities and distributors in need of immediate supply.
FAQ's of Pacliklin 260 Paclitaxel Injection:
Q: How is Pacliklin 260 Paclitaxel Injection administered?
A: Pacliklin 260 is administered intravenously by a healthcare professional in a hospital setting, following physician guidance for dilution and dosage.
Q: What are the recommended usage guidelines for Pacliklin 260?
A: The injection is intended for adult patients as directed by a physician, with the recommended dose being 260 mg in 43.4 mL, typically used for treating metastatic cancers.
Q: When should Pacliklin 260 Paclitaxel Injection be stored and used?
A: Pacliklin 260 should be stored below 25C and used within its 24-month shelf life to maintain effectiveness. Follow storage guidelines for optimal results.
Q: Where can Pacliklin 260 be purchased or supplied?
A: Pacliklin 260 Paclitaxel Injection is available through select distributors, suppliers, and traders in India, primarily for hospital and clinical supply.
Q: What is the process for handling and preparing this injection?
A: A trained medical professional will handle the preparation, ensuring proper dilution as recommended and adhering to strict safety protocols during administration.
Q: What are the benefits of choosing Pacliklin 260?
A: Pacliklin 260 offers excellent therapeutic efficacy, aligns with IP pharmacopoeia standards, and provides instant savings through competitive pricing and prompt nationwide delivery.
Send Inquiry
Send Inquiry
Send Inquiry
Send SMS
